Opportunity

DIBBS #SPE2DP-26-T-3269

DLA Solicitation for Bupropion Hydrochloride Sustained Release Tablets, 150 mg

Posted

May 06, 2026

Respond By

May 11, 2026

Identifier

SPE2DP-26-T-3269

NAICS

424210

This opportunity involves the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain soliciting Bupropion Hydrochloride Sustained Release Tablets for military use. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharm FSA, Philadelphia, PA - Contracting office: 700 Robbins Avenue, Philadelphia, PA - OEMs and Vendors: - Cardinal Health, Inc. - AmerisourceBergen Drug Corp - Sciegen Pharmaceuticals Inc - Radha Pharmaceuticals Inc - Products/Services Requested: - Bupropion Hydrochloride Sustained Release Tablets, 150 mg, 60 tablets per bottle - NSN: 6505-01-498-3167 - Multiple NDC part numbers: NDC00185-0415-60, NDC00173-0135-55, NDC00591-3541-60, NDC50228-0175-60, NDC77771-0175-60 - Quantity: 1 unit - Unique or Notable Requirements: - Commercial packaging and marking per Medical Marking Standard No. 1 - Delivery required within 20 calendar days after order - Delivery location: Fort Stewart, GA (military base) - Compliance with FDA regulations, cybersecurity, and hazardous material handling per DFARS and FAR clauses

Description

BUPROPION HYDROCHLO (QTY: 1, NSN: 6505-01-498-3167, Purchase Request: 7015009365) Approved Sources: - CAGE: 00E55, Part No: NDC00185-0415-60, Company: CARDINAL HEALTH, INC. - CAGE: 1XUY5, Part No: NDC00173-0135-55, Company: AMERISOURCEBERGEN DRUG CORP - CAGE: 1XUY5, Part No: NDC00185-0415-60, Company: AMERISOURCEBERGEN DRUG CORP - CAGE: 1XUY5, Part No: NDC00591-3541-60, Company: AMERISOURCEBERGEN DRUG CORP - CAGE: 34006, Part No: NDC00173-0135-55 - CAGE: 8NLP1, Part No: NDC50228-0175-60, Company: SCIEGEN PHARMACEUTICALS INC - CAGE: 8PNH3, Part No: NDC77771-0175-60, Company: RADHA PHARMACEUTICALS INC

View original listing